PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2009

PHARMANIAGA BERHAD

Financial Year End

31/12/2009
Quarter2
Quarterly report for the financial period ended30/06/2009
The figureshave not been audited

Attachments

pharmaniaga 2Q2009.pdf
46 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2009

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/06/2009
30/06/2008
30/06/2009
30/06/2008
RM'000
RM'000
RM'000
RM'000
1Revenue
333,212
353,465
646,928
663,115
2Profit/(loss) before tax
24,337
21,088
44,521
48,462
3Profit/(loss) for the period
18,523
13,457
33,216
32,439
4Profit/(loss) attributable to ordinary equity holders of the parent
17,697
13,107
32,219
31,652
5Basic earnings/(loss) per share (sen)
16.54
12.25
30.12
29.59
6Proposed/Declared dividend per share (sen)
27.00
18.00
27.00
18.00
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
3.7400
3.6300

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced21 Aug 2009  
CategoryFinancial Results
Reference NoPB-090818-D9224